Cesarean delivery rates in Down syndrome pregnancies

Journal of Neonatal-Perinatal Medicine

Volumn 6, Issue 2, 2013, Pages 109-115

  Faro, R ^a   Santolaya Forgas, J ^a,b   Oyelese, Y ^a,b   Di Stefano, V ^a   Canterino, J ^a,b   Ananth, C V ^c,d  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d Columbia University ^*  (United States)

Author keywords

cesarean delivery; congenital abnormalities; Down syndrome; trisomy 21

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS MORTALITY; GASTROINTESTINAL MALFORMATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; STILLBIRTH; THIRD TRIMESTER PREGNANCY; UNITED STATES; ADOLESCENT; CONGENITAL ABNORMALITIES; MATERNAL AGE; PARITY; PREGNANCY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; CESAREAN SECTION; CONGENITAL ABNORMALITIES; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PARITY; PREGNANCY; STILLBIRTH; UNITED STATES; YOUNG ADULT;

EID: 84882338579     PISSN: 19345798     EISSN: 18784429     Source Type: Journal    
DOI: 10.3233/NPM-1366512     Document Type: Article

References (36)

1. Korbel JO, Tirosh-Wagner T, Urban AE, et al. The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proceedings of the National Academy of Sciences of the United States of America 2009;104:12031-6.
2. Rachidi M, Lopes C. Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms. Neurosci Res 2007;507:349-69.
3. Sharav T, Collins RM Jr., Baab PJ. Growth studies in infants and children with Down's syndrome and elevated levels of thyrotropin. Am J Dis Child 1988;142:1302-6.
4. Kusters MA, Verstegen RH, Gemen EF, et al. Intrinsic defect of the immune system in children with Down syndrome: A review. Clin Exp Immunol 2009;156:189-93.
5. de Hingh YC, van der Vossen PW, Gemen EF, et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr 2005;147:744-7.
6. Thilaganathan B, Tsakonas D, Nicolaides K. Abnormal fetal immunological development in Down's syndrome. Br J Obstet Gynaecol 1993;100:60-2.
7. Cuadrado E, Barrena MJ. Immune dysfunction inDown's syndrome: Primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996;78:209-14.
8. Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2001;2:429-36.
9. Halliday J, Collins V, Riley M, et al. Has prenatal screening influenced the prevalence of comorbidities associated with Down syndrome and subsequent survival rates? Pediatrics 2009;123:256-61.
10. Collins VR, Muggli E, Riley M, et al. Is Down syndrome a disappearing birth defect? J Pediatr 2008;152:20-4.
11. Muggli EE, Collins VR, Marraffa C. Going down a different road: First support and information needs of families with a baby with Down syndrome. Med J Aust 2009;190: 58-61.
12. ACOG Practice Bulletin No. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217-27.
13. Borrell A, Robinson JN, Santolaya-Forgas J. Report on the 11-to 13 + 6-week ultrasound evaluation as a screening test for trisomy 21 in singleton pregnancies. Am J Perinatol 2009;26:703-10.
14. Dolk H, Loane M, Garne E, et al. Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999. Rev Epidemiol Sante Publique 2005;53(2S):87-95.
15. Egan JF, Smith K, Timms D, et al. Demographic differences in Down syndrome livebirths in the US from 1989 to 2006. Prenat Diagn 2011;31:389-94.
16. Santolaya-Forgas J, Cherry T,Weatherly K, et al. Relationship between maternal age and acceptance rate for amniocentesis procedure in a USA semirural area. Ultrasound Obstet Gynecol 2002;20(S1):23.
17. Santolaya-Forgas J, Wilkins-Haug L. Response to genetic counseling after a positive first trimester combined screening tests in women younger than 35
18. Shin M, Besser LM, Kucik JE, et al. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics 2009;124:1565-71.
19. McCabe LL, McCabe ER. Down syndrome: Coercion and eugenics. Genet Med 2011;13:708-10.
20. Barber EL, Lundsberg LS, Belanger K, et al. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol 2011;108:29-38.
21. Lockwood CJ. Why the CD rate is on the rise (Part 1). Contemporary OB GYN 2004;49:8-11.
22. Martin JA, Hamilton BE, Ventura SJ, et al. Births: Final data for 2009. National vital statistics reports: From the centers for disease control and prevention, National Center for Health Statistics, National Vital Statistics System 2011;60:1-70.
23. Zain HA, Wright JW, Parrish GE, et al. Interpreting the fetal heart rate tracing. Effect of knowledge of neonatal outcome. J Reprod Med 1998;43:367-70.
24. Pettker CM, Thung SF, Norwitz ER, et al. Impact of a comprehensive patient safety strategy on obstetric adverse events. Am J Obstet Gynecol 2009;200:491-8.
25. Gossman GL, Joesch JM, Tanfer K. Trends in maternal request cesarean delivery from 1991 to 2004. Obstet Gynecol 2006;108:1506-16.
26. Templeton A, Price J. The multiple gestation epidemic: The role of the assisted reproductive technologies. Am J Obstet Gynecol 2004;190:894-8.
27. Yang YT, Mello MM, Subramanian SV, et al. Relationship between malpractice litigation pressure and rates of cesarean section and vaginal birth after cesarean section. Med care 2009;47:234-42.
28. Taffel SM, Ventura SJ, Gay GA. Revised U.S. certificate of birth-new opportunities for research on birth outcome. Birth 1989;16:188-93.
29. Villar J, Valladares E, Wojdyla D, et al. Caesarean delivery rates and pregnancy outcomes: The 2005WHOglobal survey on maternal and perinatal health in Latin America. Lancet 2006;367:1819-29.
30. Lumbiganon P, Laopaiboon M, Gulmezoglu AM, et al. Method of delivery and pregnancy outcomes in Asia: The WHOglobal survey on maternal and perinatal health 2007-08. Lancet 2010;375:490-9.
31. MacDorman MF, Menacker F, Declercq E. Cesarean birth in the United States: Epidemiology, trends, and outcomes. Clin Perinatol 2008;35:293-307.
32. Mason JO, McGinnis JM. Healthy People 2000: An overview of the national health promotion and disease prevention objectives. Public Health Rep 1990;105:441-6.
33. Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 2002;9:2-6.
34. Zhang J, Troendle J, Reddy UM, et al. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol 2010;203:321-6.
35. Egan JF, Benn P, Borgida AF, et al. Efficacy of screening for fetal Down syndrome in the United States from 1974 to 1997. Obstet Gynecol 2000;96:979-85.
36. Menacker F, Declercq E, Macdorman MF. Cesarean delivery: Background, trends, and epidemiology. Semin Perinatol 2006;30:235-41.